Kramer, Michelle
Johnson & Johnson Pharmaceutical Research and Development Early Development, San Diego, CA, USA
3 papers on CoChatORCID 0000-0002-0946-8887
Most cited papers
- Verified
Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial
Hirschfeld, R. M. A., Keck, P. E., Kramer, M., Karcher, K., Canuso, C., Eerdekens, M., & Grossman, F. (2004) · American Journal of Psychiatry
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 273
- Verified
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol
Smulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 192
- Verified
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Berwaerts, J., Cleton, A., Rossenu, S., Talluri, K., Remmerie, B., Janssens, L., Boom, S., Kramer, M., & Eerdekens, M. (2010) · Journal of Psychopharmacology
Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism
Cited by 49
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free